Side-by-side financials for BOLT and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BOLT | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $7.70M | - |
| Net income (latest FY) | -$33.38M | - |
| Net margin | -433.7% | - |
| SEC filings | 278 | 1,004 |
Full pages: Bolt Biotherapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.